Filter News
Area of Research
- (-) Materials (28)
- (-) Supercomputing (21)
- Advanced Manufacturing (1)
- Biology and Environment (16)
- Clean Energy (44)
- Computational Engineering (1)
- Computer Science (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (10)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials for Computing (3)
- National Security (6)
- Neutron Science (10)
- Nuclear Science and Technology (8)
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (7)
- (-) Climate Change (7)
- (-) Energy Storage (20)
- (-) Exascale Computing (7)
- (-) Molten Salt (2)
- (-) Nuclear Energy (3)
- (-) Transportation (5)
- 3-D Printing/Advanced Manufacturing (15)
- Artificial Intelligence (14)
- Big Data (1)
- Bioenergy (12)
- Biology (7)
- Biotechnology (1)
- Buildings (3)
- Chemical Sciences (20)
- Composites (3)
- Computer Science (32)
- Coronavirus (7)
- Critical Materials (8)
- Cybersecurity (6)
- Decarbonization (5)
- Environment (10)
- Frontier (12)
- Fusion (2)
- Grid (5)
- High-Performance Computing (13)
- Isotopes (5)
- ITER (1)
- Machine Learning (5)
- Materials (41)
- Materials Science (37)
- Microscopy (13)
- Nanotechnology (23)
- National Security (5)
- Net Zero (1)
- Neutron Science (22)
- Partnerships (8)
- Physics (17)
- Polymers (6)
- Quantum Computing (5)
- Quantum Science (17)
- Renewable Energy (1)
- Security (4)
- Simulation (1)
- Space Exploration (1)
- Summit (14)
- Sustainable Energy (9)
- Transformational Challenge Reactor (1)
Media Contacts
Scientists at ORNL, Drexel University and their partners have discovered a way to improve the energy density of promising energy-storage materials, conductive two-dimensional ceramics called MXenes.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.